The U.S. enteral nutrition market is experiencing steady and sustained growth, reflecting broader trends in healthcare delivery and chronic disease management. As of 2023, the market was valued at approximately $2.84 billion, representing a significant portion of the global enteral feeding devices market, which stood at $4.3 billion. Projections indicate that the U.S. market will grow to $3.9 billion by 2025 and further expand to $5.9 billion by 2030, supported by compound annual growth rates (CAGR) of 6.7% from 2020 to 2025 and 4.4% from 2024 to 2030. This growth underscores the increasing reliance on enteral nutrition as a critical component of patient care, particularly for individuals who are unable to meet their nutritional needs through oral intake alone. Enteral nutrition is now widely recognized not only as a life-sustaining intervention but also as a means of improving clinical outcomes and reducing healthcare costs.
